Clinical trial
A Pilot Study for the Treatment of Patients With Metastatic and High Risk…
NCT00001209 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001209 |
|---|---|
| Title | A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors |
| Official title | A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neuroectodermal Tumor, Primitive, Neuroepithelioma, Osteosarcoma, Sarcoma, Ewing's |
| Intervention type | Drug |
| Interventions | vincristine, adriamycin and cytoxan, alternating with ifosfamide VP-16 |
| Enrollment | 120 |
| Start date | Oct 1, 1986 |
| Completion | Aug 1, 2000 |
| First posted | Dec 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: